Wellscience Health Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 16-12-2024
- Paid Up Capital ₹ 0.13 M
as on 16-12-2024
- Company Age 15 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 7.44%
(FY 2023)
- Profit -47.54%
(FY 2023)
- Ebitda -11.28%
(FY 2023)
- Net Worth 16.66%
(FY 2023)
- Total Assets 4.56%
(FY 2023)
About Wellscience Health
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.13 M, as per Ministry of Corporate Affairs (MCA) records.
Witty Bawa and Lajinder Bawa serve as directors at the Company.
- CIN/LLPIN
U85190DL2009PTC187283
- Company No.
187283
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Feb 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Wellscience Health Private Limited offer?
Wellscience Health Private Limited offers a wide range of products and services, including Health Care Service, Women Health Services, Liver Supplement, Ayurvedic Liver Tablets Capsules, Nutraceuticals, Ayurvedic Medicine, Ayurvedic Kidney Medicine, Ayurvedic Digestive Medicine, Digestive Herbal Capsule & Tablet, Cardiac Drugs.
Who are the key members and board of directors at Wellscience Health?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Lajinder Bawa | Director | 05-Feb-2009 | Current |
Witty Bawa | Director | 01-Sep-2016 | Current |
Financial Performance of Wellscience Health.
Wellscience Health Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.44% increase. The company also saw a substantial fall in profitability, with a 47.54% decrease in profit. The company's net worth Soared by an impressive increase of 16.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Wellscience Health?
In 2023, Wellscience Health had a public holding of 15.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Aayu Health Sciences Private LimitedActive 8 months 13 days
Witty Bawa and Lajinder Bawa are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Wellscience Health?
Unlock and access historical data on people associated with Wellscience Health, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wellscience Health, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wellscience Health's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.